Global Daptomycin Drug Market: Introduction

Daptomycin drug medication is an antibiotic used to treat serious bacterial infections. It stops the growth of bacteria. Dosage is based on the patient’s weight, medical condition, and response to treatment. In children, the dosage is also based on age and weight. The drug is not recommended for children below the age of 12 months. Daptomycin has numerous FDA-approved and off-label clinical uses, such as complicated skin and skin structure infections (cSSSI) in adult and pediatric patients and S. aureus bacteremia in adult patients, including those with right-sided infective endocarditis. Daptomycin is a cyclic lipopeptide antibiotic that exerts its bactericidal effect by disrupting multiple aspects of bacterial cell membrane function.

Key Drivers of Global Daptomycin Drug Market

Rise in infections in the bloodstream

Bloodstream infections are infective endocarditis, central venous catheter-associated bloodstream infections, primary bacteremia, and those with secondary bacteremia due to focal infections including abscesses, osteomyelitis, urinary tract infections, or pneumonia. An infectious pathogen reaches the bloodstream by direct invasion into blood vessels, via lymphatic vessels, draining a focus of infection such as an abscess or through vascular devices such as needles of catheters. Slurred speech or confusion, extreme shivering or muscle pain, oliguria, respiratory problems, and a pale skin with a falling blood pressure are all symptoms potentially associated with initial sepsis. Bloodstream infections (BSIs) are among the highly severe human infections, with markedly high rates of morbidity and mortality.

Rise of right-sided infective endocarditis

According to Annals of Cardiothoracic Surgery, Right-sided infective endocarditis (RSIE) is less common than left-sided infective endocarditis (IE), are only 5% to 10% of cases of IE. Endocarditis affecting the right heart chambers and valves has typical etiologies and epidemiology as well as unique diagnostic and therapeutic options. Right-sided infective endocarditis is due to intravenous drug abuse. Right-sided infective endocarditis related to drug abuse mostly affects the tricuspid valve and rarely the pulmonary valve. According to IntechOpen, in the U.S., North Carolina, a study reported a 12-fold increase in hospitalizations for intravenous drug use related IE over the last decade. Right-sided infective endocarditis (RSIE) can be classified into three epidemiological groups: intravenous drug users (IDUs), intravascular device carriers, and the ‘three noes’ group that is no left-sided, no device, no IDUs.

North America to Account for Major Share of Global Daptomycin Drug Market

  • North America is projected to account for major share of the global daptomycin drug market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development and various government initiatives. Europe is expected to be the second-largest market during the forecast period.
  • The daptomycin drug market in Asia Pacific is likely to expand at a high CAGR during the forecast period. This can be attributed to a rise in investment in research & development by private & government organizations and increase in healthcare management.

Key Players Operating in Global Daptomycin Drug Market

The global daptomycin drug market is highly consolidated owing to the presence of numerous key players. Leading players operating in the global daptomycin drug market include:

  • Teva Pharmaceutical Industries Ltd.
  • Merck &co.
  • Cipla
  • Pfizer
  • BE Pharmaceuticals
  • Reddy’s Laboratories
  • Mylan
  • Fresenius Kabi
  • Nichi-Iko Pharmaceutical
  • Novo Holdings A/S

Global Daptomycin Drug Market: Research Scope

Global Daptomycin Drug Market, by Indication

  • Complicated Skin Structure infections
  • Bacteremia
  • Others

Global Daptomycin Drug Market, by Age Group

  • Pediatric
  • Adult

Global Daptomycin Drug Market, by Dosage

  • 350 mg
  • 500 mg

Global Daptomycin Drug Market, by Distribution Channel

  • Hospitals Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Global Daptomycin Drug Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Daptomycin Drug Market

Pre Book